Christopher Towler

OBS Medical Ltd. manufactures and distributes physiological monitoring and patient monitoring devices. Its product Visensia, a physiological monitoring system for detecting early clinical patient deterioration. The firm operates as a predictive software company that provides products and services for the hospital, community and consumer health care markets. It develops and support products that enable their customers, both patients and healthcare professionals, to manage and monitor health conditions more effectively through simplification, risk identification and prevention. The company was founded in 2000 and is headquartered in Abingdon, the United Kingdom.

Oxford Spin-out Equity Management (OSEM) is wholly-owned subsidiary of University of Oxford. The firm headquartered at UK. Since 2008, OSEM is responsible for spinout companies.

Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom.

OBS Medical Ltd. manufactures and distributes physiological monitoring and patient monitoring devices. Its product Visensia, a physiological monitoring system for detecting early clinical patient deterioration. The firm operates as a predictive software company that provides products and services for the hospital, community and consumer health care markets. It develops and support products that enable their customers, both patients and healthcare professionals, to manage and monitor health conditions more effectively through simplification, risk identification and prevention. The company was founded in 2000 and is headquartered in Abingdon, the United Kingdom.

Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom.

OBS Medical Ltd. manufactures and distributes physiological monitoring and patient monitoring devices. Its product Visensia, a physiological monitoring system for detecting early clinical patient deterioration. The firm operates as a predictive software company that provides products and services for the hospital, community and consumer health care markets. It develops and support products that enable their customers, both patients and healthcare professionals, to manage and monitor health conditions more effectively through simplification, risk identification and prevention. The company was founded in 2000 and is headquartered in Abingdon, the United Kingdom.

OBS Medical Ltd. manufactures and distributes physiological monitoring and patient monitoring devices. Its product Visensia, a physiological monitoring system for detecting early clinical patient deterioration. The firm operates as a predictive software company that provides products and services for the hospital, community and consumer health care markets. It develops and support products that enable their customers, both patients and healthcare professionals, to manage and monitor health conditions more effectively through simplification, risk identification and prevention. The company was founded in 2000 and is headquartered in Abingdon, the United Kingdom.